Christoph Kasper

1.7k total citations
36 papers, 1.3k citations indexed

About

Christoph Kasper is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Christoph Kasper has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Christoph Kasper's work include Hematopoietic Stem Cell Transplantation (6 papers), Erythropoietin and Anemia Treatment (4 papers) and Chemokine receptors and signaling (4 papers). Christoph Kasper is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Erythropoietin and Anemia Treatment (4 papers) and Chemokine receptors and signaling (4 papers). Christoph Kasper collaborates with scholars based in Germany, Switzerland and United Kingdom. Christoph Kasper's co-authors include Cécile Arrieumerlou, Victor Sourjik, Christian Spangler, Hui Li, Volker Röth, Matthias Kaiser, Martin Ackermann, Alex Boehm, Volkhard Kaever and Urs Jenal and has published in prestigious journals such as Cell, The Journal of Cell Biology and Blood.

In The Last Decade

Christoph Kasper

36 papers receiving 1.3k citations

Peers

Countries citing papers authored by Christoph Kasper

Since Specialization

Citations

This map shows the geographic impact of Christoph Kasper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Kasper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Kasper more than expected).

Fields of papers citing papers by Christoph Kasper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Kasper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Kasper. The network helps show where Christoph Kasper may publish in the future.

Co-authorship network of co-authors of Christoph Kasper

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Kasper. A scholar is included among the top collaborators of Christoph Kasper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Kasper. Christoph Kasper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Systems-Level Overview of Host Protein Phosphorylation During Shigella flexneri Infection Revealed by Phosphoproteomics 2013 ·Molecular & Cellular Proteomics ·(unknown), Erik Ahrné, Christoph Kasper, (unknown), Isabel Sorg, Roland F. Dreier, Alexander Schmidt, Cécile Arrieumerlou	48
2	Second Messenger-Mediated Adjustment of Bacterial Swimming Velocity 2010 ·Cell ·Alex Boehm, Matthias Kaiser, Hui Li, Christian Spangler, Christoph Kasper, Martin Ackermann, Volkhard Kaever, Victor Sourjik, Volker Röth, Urs Jenal	357
3	Cell-Cell Propagation of NF-κB Transcription Factor and MAP Kinase Activation Amplifies Innate Immunity against Bacterial Infection 2010 ·Immunity ·Christoph Kasper, Isabel Sorg, (unknown), (unknown), Harry Wischnewski, (unknown), Cécile Arrieumerlou	93
4	Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma,results of a phase II single center study 2005 ·Annals of Hematology ·(unknown), Christoph Kasper, Holger Nückel, Ulrich Dührsen	13
5	Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans 2005 ·International Journal of Cardiology ·Friedhelm Kuethe, Barbara M. Richartz, Christoph Kasper, Herbert G. Sayer, Klaus Hoeffken, Gerald S. Werner, Hans R. Figulla	33
6	Interferon alpha (IFN) treatment of bone marrow stroma inhibits haematopoesis 2004 ·Leukemia Research ·Christoph Kasper, Anna Lübking, Dietrich W. Beelen, (unknown)	1
7	Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment 2004 ·European Journal of Cancer ·Karin Jordan, Christoph Kasper, Hans‐Joachim Schmoll	103
8	Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors 2004 ·Bone Marrow Transplantation ·Christoph Kasper, Herbert G. Sayer, Lars‐Olof Mügge, K Schilling, Sebastian Scholl, (unknown), K. Höffken	20
9	Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCT 2004 ·Bone Marrow Transplantation ·Sebastian Scholl, Lars‐Olof Mügge, (unknown), Christoph Kasper, Katharina Pachmann, K. Höffken, Herbert G. Sayer	12
10	Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation 2004 ·Journal of Cancer Research and Clinical Oncology ·Sebastian Scholl, Herbert G. Sayer, (unknown), Christoph Kasper, (unknown), (unknown), Joachim H. Clement, K. H�ffken	15
11	Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes 2002 ·Journal of Cancer Research and Clinical Oncology ·Christoph Kasper, (unknown), Herbert G. Sayer	19
12	Recombinant human erythropoietin in the treatment of anemic patients with hematological malignancies 2001 ·Annals of Hematology ·Christoph Kasper	17
13	Biological effects of stroma-derived factor-1α on normal and CML CD34+ haemopoietic cells 2000 ·Leukemia ·Jan Dürig, C. Julian Rosenthal, AH Elmaagacli, C M Heyworth, (unknown), Christoph Kasper, J Novotný, Ulrich Dührsen	35
14	Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1α 1999 ·Leukemia ·Jan Dürig, NG Testa, B. I. Lord, Christoph Kasper, James Chang, Nick Telford, TM Dexter, C M Heyworth	13
15	Content of long‐term culture‐initiating cells, clonogenic progenitors and CD34⁺cells in apheresis harvests of normal donors for allogeneic transplantation, and in patients with acute myeloid leukaemia or multiple myeloma 1999 ·British Journal of Haematology ·Christoph Kasper, W. David J. Ryder, Jan Dürig, (unknown), J H Scarffe, Dietrich W. Beelen, UW Schaefer, Jennifer C. Chang, Nydia G. Testa	5
16	Splenic rupture in a patient with acute myeloid leukemia undergoing peripheral blood stem cell transplantation 1999 ·Annals of Hematology ·Christoph Kasper, Lydia Jones, Yasuko Fujita, G.R. Morgenstern, J.H. Scarffe, James Chang	25
17	Recombinant human megakaryocyte growth and development factor (MGDF) increases the numbers of megakaryocyte progenitor cells to normal values in long-term bone marrow cultures of patients with AML in first remission 1998 ·Leukemia ·Christoph Kasper, Adrian Schwarzer, (unknown), James Chang, TM Dexter, Robert E. J. Ryder, NG Testa	1
18	Bolus vincristine and epirubicin with cyclophosphamide and dexamethasone (VECD) as induction and salvage treatment in multiple myeloma 1998 ·Leukemia ·Alexander Fosså, (unknown), Christoph Kasper, (unknown), S. Seeber, M. R. Nowrousian	12
19	In vitro Effects of Recombinant Human Megakaryocyte Growth and Development Factor on Primary Human Tumour Colony Growth 1997 ·Oncology ·Shona Lang, Catharine West, Lyndon Jones, (unknown), Christoph Kasper, (unknown), Nydia G. Testa	3
20	Recombinant human erythropoietin in the treatment of cancer‐related anaemia 1997 ·European Journal Of Haematology ·Christoph Kasper, (unknown), Alexander Fosså, Anja Welt, S. Seeber, M. R. Nowrousian	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact